HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Holcenberg Selected Research

myelin basic protein 84-102

4/2000A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Holcenberg Research Topics

Disease

1Neoplasms (Cancer)
03/2001
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2001
1Multiple Sclerosis
04/2000

Drug/Important Bio-Agent (IBA)

1Thioguanine (Tioguanine)FDA Link
03/2001
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
03/2001
1myelin basic protein 84-102IBA
04/2000